EnginZyme Competitors and Similar CompaniesClear all

EnginZyme's competitors and similar companies include Novozymes, Lonza, GreenLight Biosciences and Rocky Mountain Labs.

	EnginZyme EnginZyme is a biotechnology company that specializes in biocatalysis.	Novozymes Novozymes is a company that specializes in the production and distribution of enzymes and microorganisms.	Lonza Lonza Group is a company specializing in life sciences and biotechnology solutions	GreenLight Biosciences GreenLight Biosciences is a company that develops sustainable crop protection solutions.	Rocky Mountain Labs Rocky Mountain Laboratories is a company operating as a surface chemistry and microanalysis laboratory.
Founding Date	Founding Date 2014	Founding Date 2000	Founding Date 1897	Founding Date 2008	Founding Date 1983
Type	Type Private	Type Subsidiary	Type Public	Type Subsidiary	Type Private
Tags	Tags Technology biotech chemicals	Tags Manufacturing & Industrial biotech chemicals life sciences	Tags Healthcare biotech chemicals life sciences pharma	Tags Manufacturing & Industrial agriculture materials agritech biotech chemicals	Tags Manufacturing & Industrial biotech chemicals clinical research life sciences
Locations	Locations Solna, SE HQ	Locations Bagsværd, DK HQ Buenos Aires, AR North Rocks, AU Watermael Boitsfort, BE Barigui, BR Quatro Barras, BR Ottawa, CA see more	Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more	Locations Medford, US HQ Durham, US St. Louis, US	Locations Golden, US HQ
Employees	Employees 442% increase	Employees 6,7561% decrease	Employees 19,7712% increase	Employees 2102% increase	Employees 284% increase
Financial
Revenue (est.)	Revenue (est.) kr20.6m (FY, 2024)	Revenue (est.) €4.2b (FY, 2025)	Revenue (est.) CHF6.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods kr19.5m (FY, 2024)	Cost of goods €1.6b (FY, 2025)	Cost of goods CHF2.1b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr1.1m (FY, 2024)	Gross profit €2.6b (FY, 2025)	Gross profit CHF4.5b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income (kr72.8m) (FY, 2024)	Net income €583.6m (FY, 2025)	Net income CHF909m (FY, 2025)	Net income N/A	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 140 (FY, 2022)	Countries 28 (FY, 2022)	Countries N/A	Countries N/A
Funding
Total funding raised	Total funding raised $ 11.5m	Total funding raised $ 45.1m	Total funding raised N/A	Total funding raised $ 215m	Total funding raised N/A